Wangsu Selling General Administrative vs Research Development Analysis

300017 Stock

9.40 0.15 1.57%

Wangsu Science financial indicator trend analysis is more than just analyzing Wangsu Science Tech current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Wangsu Science Tech is a good investment. Please check the relationship between Wangsu Science Selling General Administrative and its Research Development accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Wangsu Science Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative vs Research Development

Selling General Administrative vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Wangsu Science Tech Selling General Administrative account and Research Development. At this time, the significance of the direction appears to have strong relationship.

The correlation between Wangsu Science's Selling General Administrative and Research Development is 0.63. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Research Development in the same time period over historical financial statements of Wangsu Science Tech, assuming nothing else is changed. The correlation between historical values of Wangsu Science's Selling General Administrative and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Wangsu Science Tech are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling General Administrative i.e., Wangsu Science's Selling General Administrative and Research Development go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Selling General Administrative

Research Development

Most indicators from Wangsu Science's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Wangsu Science Tech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Wangsu Science Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Selling General Administrative is expected to grow to about 287.2 M. The current year's Tax Provision is expected to grow to about 47.2 M

	2021	2022	2023	2024 (projected)
Income Before Tax	137.7M	194.1M	651.4M	382.9M
Cost Of Revenue	3.4B	3.8B	3.2B	2.1B

Income Before Tax Cost Of Revenue

Wangsu Science fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Inventory	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Long Term Debt	Intangible Assets	Other Liab	Net Tangible Assets	Short Term Investments	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total
Total Assets		0.4	0.92	0.93	0.93	0.96	0.76	0.64	0.95	0.12	0.47	0.88	0.88	0.9	0.52	0.63	0.52	0.93	0.66	-0.61	0.88	0.91	0.87	0.81	0.57	-0.01
Other Current Liab	0.4		0.48	0.25	0.25	0.35	0.56	0.46	0.5	0.65	0.12	0.51	0.08	0.36	0.32	0.55	0.68	0.17	0.11	0.29	0.04	0.07	0.3	0.08	-0.21	0.33
Total Current Liabilities	0.92	0.48		0.81	0.83	0.95	0.7	0.63	0.95	0.04	0.67	0.99	0.8	0.97	0.66	0.83	0.7	0.75	0.44	-0.43	0.77	0.83	0.73	0.82	0.32	0.31
Total Stockholder Equity	0.93	0.25	0.81		0.99	0.87	0.7	0.57	0.86	0.09	0.37	0.77	0.96	0.79	0.42	0.46	0.37	0.97	0.74	-0.74	0.9	0.87	0.92	0.83	0.65	-0.2
Retained Earnings	0.93	0.25	0.83	0.99		0.89	0.63	0.53	0.88	0.01	0.39	0.78	0.97	0.8	0.43	0.48	0.38	0.95	0.75	-0.75	0.92	0.89	0.9	0.83	0.63	-0.2
Accounts Payable	0.96	0.35	0.95	0.87	0.89		0.66	0.56	0.98	-0.04	0.56	0.92	0.87	0.93	0.56	0.73	0.6	0.84	0.57	-0.54	0.87	0.91	0.78	0.83	0.46	0.13
Cash	0.76	0.56	0.7	0.7	0.63	0.66		0.66	0.68	0.59	0.36	0.71	0.53	0.67	0.49	0.54	0.65	0.65	0.31	-0.21	0.47	0.5	0.68	0.53	0.34	0.18
Other Assets	0.64	0.46	0.63	0.57	0.53	0.56	0.66		0.57	0.17	0.01	0.61	0.55	0.61	0.13	0.64	0.54	0.52	0.09	-0.16	0.31	0.6	0.43	0.62	0.43	0.05
Net Receivables	0.95	0.5	0.95	0.86	0.88	0.98	0.68	0.57		0.06	0.54	0.93	0.83	0.92	0.57	0.77	0.66	0.82	0.57	-0.45	0.83	0.85	0.78	0.8	0.4	0.16
Inventory	0.12	0.65	0.04	0.09	0.01	-0.04	0.59	0.17	0.06		-0.1	0.08	-0.18	-0.06	0.05	-0.02	0.31	0.08	0.14	0.27	-0.16	-0.28	0.3	-0.28	-0.22	0.08
Other Current Assets	0.47	0.12	0.67	0.37	0.39	0.56	0.36	0.01	0.54	-0.1		0.7	0.38	0.71	0.81	0.58	0.46	0.3	0.11	-0.21	0.53	0.41	0.35	0.52	-0.05	0.62
Total Liab	0.88	0.51	0.99	0.77	0.78	0.92	0.71	0.61	0.93	0.08	0.7		0.75	0.97	0.69	0.86	0.77	0.69	0.37	-0.34	0.72	0.77	0.69	0.79	0.25	0.4
Common Stock	0.88	0.08	0.8	0.96	0.97	0.87	0.53	0.55	0.83	-0.18	0.38	0.75		0.8	0.4	0.48	0.32	0.92	0.65	-0.79	0.91	0.94	0.81	0.91	0.71	-0.21
Property Plant Equipment	0.9	0.36	0.97	0.79	0.8	0.93	0.67	0.61	0.92	-0.06	0.71	0.97	0.8		0.68	0.85	0.68	0.74	0.36	-0.4	0.8	0.86	0.66	0.89	0.41	0.36
Long Term Debt	0.52	0.32	0.66	0.42	0.43	0.56	0.49	0.13	0.57	0.05	0.81	0.69	0.4	0.68		0.58	0.53	0.33	0.13	-0.15	0.48	0.39	0.34	0.5	0.04	0.51
Intangible Assets	0.63	0.55	0.83	0.46	0.48	0.73	0.54	0.64	0.77	-0.02	0.58	0.86	0.48	0.85	0.58		0.85	0.37	-0.02	0.08	0.41	0.57	0.34	0.68	0.05	0.65
Other Liab	0.52	0.68	0.7	0.37	0.38	0.6	0.65	0.54	0.66	0.31	0.46	0.77	0.32	0.68	0.53	0.85		0.25	-0.08	0.26	0.22	0.32	0.29	0.44	-0.08	0.68
Net Tangible Assets	0.93	0.17	0.75	0.97	0.95	0.84	0.65	0.52	0.82	0.08	0.3	0.69	0.92	0.74	0.33	0.37	0.25		0.81	-0.78	0.93	0.89	0.93	0.78	0.71	-0.29
Short Term Investments	0.66	0.11	0.44	0.74	0.75	0.57	0.31	0.09	0.57	0.14	0.11	0.37	0.65	0.36	0.13	-0.02	-0.08	0.81		-0.77	0.76	0.58	0.87	0.35	0.39	-0.5
Other Stockholder Equity	-0.61	0.29	-0.43	-0.74	-0.75	-0.54	-0.21	-0.16	-0.45	0.27	-0.21	-0.34	-0.79	-0.4	-0.15	0.08	0.26	-0.78	-0.77		-0.81	-0.72	-0.7	-0.57	-0.67	0.59
Deferred Long Term Liab	0.88	0.04	0.77	0.9	0.92	0.87	0.47	0.31	0.83	-0.16	0.53	0.72	0.91	0.8	0.48	0.41	0.22	0.93	0.76	-0.81		0.91	0.83	0.82	0.64	-0.16
Long Term Investments	0.91	0.07	0.83	0.87	0.89	0.91	0.5	0.6	0.85	-0.28	0.41	0.77	0.94	0.86	0.39	0.57	0.32	0.89	0.58	-0.72	0.91		0.73	0.91	0.71	-0.11
Total Current Assets	0.87	0.3	0.73	0.92	0.9	0.78	0.68	0.43	0.78	0.3	0.35	0.69	0.81	0.66	0.34	0.34	0.29	0.93	0.87	-0.7	0.83	0.73		0.61	0.43	-0.2
Non Current Assets Total	0.81	0.08	0.82	0.83	0.83	0.83	0.53	0.62	0.8	-0.28	0.52	0.79	0.91	0.89	0.5	0.68	0.44	0.78	0.35	-0.57	0.82	0.91	0.61		0.68	0.08
Non Currrent Assets Other	0.57	-0.21	0.32	0.65	0.63	0.46	0.34	0.43	0.4	-0.22	-0.05	0.25	0.71	0.41	0.04	0.05	-0.08	0.71	0.39	-0.67	0.64	0.71	0.43	0.68		-0.53
Non Current Liabilities Total	-0.01	0.33	0.31	-0.2	-0.2	0.13	0.18	0.05	0.16	0.08	0.62	0.4	-0.21	0.36	0.51	0.65	0.68	-0.29	-0.5	0.59	-0.16	-0.11	-0.2	0.08	-0.53

Click cells to compare fundamentals

Wangsu Science Account Relationship Matchups

Wangsu Science fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.3B	10.2B	10.6B	10.5B	11.0B	5.7B
Other Current Liab	164.8M	349.2M	196.1M	6.0M	16.5M	15.7M
Total Current Liabilities	1.4B	1.4B	1.6B	1.3B	1.1B	849.9M
Total Stockholder Equity	8.6B	8.7B	8.8B	9.0B	9.6B	10.1B
Retained Earnings	4.1B	4.2B	4.4B	3.9B	4.3B	4.5B
Accounts Payable	879.5M	708.0M	705.5M	748.3M	568.0M	386.5M
Cash	1.6B	1.2B	1.0B	2.5B	1.8B	1.3B
Other Assets	272.5M	354.9M	383.5M	401.8M	462.1M	251.9M
Net Receivables	1.7B	1.7B	1.4B	1.2B	1.1B	811.7M
Inventory	10.3M	6.1M	12.2M	30.5M	13.5M	12.8M
Other Current Assets	213.4M	136.3M	340.5M	462.9M	285.0M	250.3M
Total Liab	1.7B	1.5B	1.7B	1.4B	1.2B	990.7M
Common Stock	2.4B	2.4B	2.5B	2.4B	2.8B	3.0B
Property Plant Equipment	3.3B	1.8B	1.6B	1.5B	1.7B	907.4M
Intangible Assets	468.8M	323.0M	164.2M	80.5M	45.0M	42.7M
Other Liab	413.9M	309.7M	66.1M	45.5M	52.3M	49.7M
Net Tangible Assets	7.3B	8.2B	8.4B	8.7B	10.0B	7.6B
Short Term Investments	2.4B	2.6B	3.6B	2.2B	2.5B	2.3B
Other Stockholder Equity	(60.4M)	(33.5M)	(132.4M)	(210.3M)	(189.2M)	(179.8M)
Deferred Long Term Liab	59.7M	48.1M	54.2M	51.4M	59.2M	41.9M
Total Current Assets	6.0B	5.7B	7.4B	6.5B	5.7B	6.3B
Non Current Assets Total	4.3B	4.5B	3.2B	4.0B	5.2B	4.7B
Non Currrent Assets Other	1.1B	1.7B	576.2M	1.7B	2.6B	1.4B
Non Current Liabilities Total	309.7M	66.1M	107.5M	82.8M	79.2M	75.3M
Common Stock Shares Outstanding	2.4B	2.5B	2.4B	2.4B	2.4B	2.7B
Net Invested Capital	8.8B	8.8B	9.3B	9.2B	9.7B	10.1B
Short Long Term Debt	135.7M	145.3M	503.9M	144.8M	80.1M	76.1M
Net Working Capital	4.6B	4.3B	5.8B	5.1B	4.6B	4.8B
Capital Stock	2.4B	2.5B	2.4B	2.4B	2.4B	2.7B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Wangsu Stock

Balance Sheet is a snapshot of the financial position of Wangsu Science Tech at a specified time, usually calculated after every quarter, six months, or one year. Wangsu Science Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Wangsu Science and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Wangsu currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Wangsu Selling General Administrative vs Research Development Analysis

Selling General Administrative vs Research Development

Selling General Administrative vs Research Development Correlation Analysis

Correlation Coefficient

Selling General Administrative

Research Development

Wangsu Science fundamental ratios Correlations

Wangsu Science Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Wangsu Science fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Wangsu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Total Current Liabilities
Retained Earnings	+ 0.99	Total Stockholder Equity
Net Receivables	+ 0.98	Accounts Payable
Property Plant Equipment	+ 0.97	Total Current Liabilities
Net Tangible Assets	+ 0.97	Total Stockholder Equity
Common Stock	+ 0.97	Retained Earnings

Deferred Long Term Liab	- 0.81	Other Stockholder Equity
Other Stockholder Equity	- 0.79	Common Stock
Other Stockholder Equity	- 0.78	Net Tangible Assets
Other Stockholder Equity	- 0.77	Short Term Investments
Other Stockholder Equity	- 0.75	Retained Earnings
Other Stockholder Equity	- 0.74	Total Stockholder Equity